公开(公告)号：US20140056920A1

公开(公告)日：2014-02-27

申请号：US13971334

申请日：2013-08-20

Applicant: Marius ARDELEANU ,  Namita A. GANDHI ,  Neil GRAHAM ,  Stephane C. KIRKESSELI ,  Sudeep KUNDU ,  Ross E. ROCKLIN ,  Allen RADIN ,  Steven P. WEINSTEIN ,  Jennifer Davidson HAMILTON ,  Jeffrey MING

Inventor： Marius ARDELEANU ,  Namita A. GANDHI ,  Neil GRAHAM ,  Stephane C. KIRKESSELI ,  Sudeep KUNDU ,  Ross E. ROCKLIN ,  Allen RADIN ,  Steven P. WEINSTEIN ,  Jennifer Davidson HAMILTON ,  Jeffrey MING

IPC: C07K16/28 ,  A61K39/395 ,  A61K45/06

CPC classification number: C07K16/2866 ,  A61K39/39541 ,  A61K39/3955 ,  A61K45/06 ,  A61K2039/505 ,  A61K2039/54 ,  C07K16/247 ,  C07K2317/21 ,  C07K2317/565 ,  C07K2317/76 ,  C12Q1/6883 ,  C12Q2600/106 ,  C12Q2600/158 ,  G01N33/6854 ,  G01N33/6863 ,  G01N33/6893 ,  G01N2333/521 ,  G01N2800/122 ,  G01N2800/52

Abstract: The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.

Abstract translation: 本发明提供了治疗或预防患者的哮喘和相关病症的方法。 本发明的方法包括向有需要的受试者施用包含白细胞介素-4受体（IL-4R）拮抗剂如抗IL-4R抗体的治疗组合物。